Use of chemotherapy and immunotherapy in the last two months of life in a French institutional anticancer center, 2008-2009.

e19656 Background: Despite improvements in the outcome of solid malignancy, a great number of patients (pts) will died from their affliction. The timing for cessation of oncologic treatment is diff...